BALYASNY ASSET MANAGEMENT L.P. - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 209 filers reported holding MIRATI THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.6%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q4 2023$2,227,859
-93.4%
37,921
-95.1%
0.00%
-94.2%
Q3 2023$33,791,539
+1396.7%
775,747
+1177.5%
0.07%
+1050.0%
Q1 2023$2,257,718
+9.4%
60,724
+33.3%
0.01%0.0%
Q4 2022$2,063,463
-87.9%
45,541
-41.2%
0.01%
-93.7%
Q4 2020$17,014,000
+2740.4%
77,464
+1567.7%
0.10%
+2275.0%
Q4 2019$599,000
-81.2%
4,645
-93.8%
0.00%
-82.6%
Q4 2018$3,189,000
-33.5%
75,166
-18.9%
0.02%
+4.5%
Q3 2018$4,796,000
+2041.1%
92,732
+653.9%
0.02%
+2100.0%
Q4 2017$224,000
-11.5%
12,300
-43.1%
0.00%0.0%
Q3 2017$253,0000.0%21,600
+169.3%
0.00%
-50.0%
Q4 2015$253,000
-83.5%
8,020
-84.7%
0.00%
-83.3%
Q1 2015$1,535,00052,3420.01%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$257,839,00068.01%
Boxer Capital, LLC 2,000,000$164,440,0008.45%
Avoro Capital Advisors LLC 5,325,000$437,822,0007.99%
M28 Capital Management LP 82,900$6,816,0006.27%
Artal Group S.A. 1,350,000$110,997,0004.65%
Nextech Invest Ltd. 173,300$14,249,0004.07%
Perceptive Advisors 2,380,710$195,742,0003.92%
Logos Global Management LP 350,000$28,777,0003.73%
Camber Capital Management LP 1,200,000$98,664,0003.57%
RTW INVESTMENTS, LP 1,561,497$128,386,0002.66%
View complete list of MIRATI THERAPEUTICS INC shareholders